NinePointTwo Capital’s Transmedics TMDX Stock Holding History

NinePointTwo Capital’s Portfolio TMDX Stock Details TMDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	$621K	Buy	+7,879	New	+$475K	0.25%	31
2023 Q3	–	Sell	-3,393	Closed	-$284K	–	322
2023 Q2	$284K	Buy	+3,393	New	+$260K	0.11%	69

Other funds holding TMDX

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

FAM

Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

DCM

Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return

Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

EAM

Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return

NinePointTwo Capital's TMDX Position: Q4 2023 in Review

NinePointTwo Capital opened a new position in Transmedics (TMDX) in Q4 2023: 7,879 shares worth $621K. The stake represents 0.25% of the portfolio and ranks #31 among its holdings. This is a return to the name: NinePointTwo Capital previously reported a position in TMDX as recently as Q2 2023.

NinePointTwo Capital first reported a position in TMDX in Q2 2023 and has held it in 2 quarters since. 248 funds tracked by Wall St. Rank hold TMDX as of Q4 2023.

NinePointTwo Capital held 7,879 shares of Transmedics worth $621K as of Q4 2023.
Transmedics was a new NinePointTwo Capital position in Q4 2023.
Transmedics made up 0.25% of NinePointTwo Capital's portfolio in Q4 2023, its #31 holding.
NinePointTwo Capital first reported a position in Transmedics in Q2 2023 and has held it in 2 quarters since.
248 funds tracked by Wall St. Rank held Transmedics as of Q4 2023.

Based on NinePointTwo Capital's 13F filing for Q4 2023, filed 14 Feb 2024.